De-Risking Investments in Medical Technology Innovation
Strengthening decision-making and valuation accuracy in early-stage medical startups.
The high failure rates of medical startups have discouraged many potential investors, depriving the sector of precious financial resources. In the last two decades, managing early-stage medical technology ventures hasn’t gotten easier: it still means facing high levels of complexity due to many factors, such as the challenging prediction of the behavior of numerous stakeholders with conflicting priorities, the stretched breadth of competencies required of medical entrepreneurs, and the fast accelerating rate of growth of global medical knowledge. The reader of this book will find practical tools that help navigate the map of critical decision problems—those inhabiting the critical path that begins with an innovative idea and ends with the highly sought-after monetization. Addressing these problems with high-quality decisions can make the difference between successful value creation and expensive failure.
_PNG.png)
The Springer Series in Healthcare Management and Innovation presents a curated collection of research monographs, contributed volumes, and professional titles that illuminate emerging theories, empirical studies, practical applications, strategic frameworks, and real-world case studies in healthcare. Each volume addresses a broad spectrum of topics in healthcare management and innovation, including—but not limited to—leadership, financial management, ethics and corporate social responsibility (CSR), human resource management, managed care, workforce and patient diversity, research and development (R&D) of medical technologies, organizational strategy and planning, and healthcare information systems.
C
Dr. Luigi Negri is Founder and CEO for ThinKeen® Global Consulting (Miami, FL, USA) and Venture Partner of Obloo® Ventures Consulting (Milano, Italy). In this role, he has supported investors in the appraisal and valuation of target medical startups, he has been a board member of highly innovative medical startups and served as a member of advisory boards of broader public initiatives focused on evaluating larger populations of life science startups.
In the previous twenty years, Luigi has succeeded as an executive in several international corporate assignments with general management responsibilities in the biotechnology and medical devices industry across multiple global corporations and geographical regions.
These positions included VP of Northern & Central Europe for Becton Dickinson® (CR Bard), VP of Emerging Markets of Latin America at Baxter Health Care, and Area General Manager for Poland & Russian Federation at Baxter Health Care®.
Luigi holds a MS in Electronic Engineering and Semiconductors’ Physics from the University of Bologna (Italy), an MBA froom the University of Kansas and a Doctorate in Business Administration from SDA Bocconi (Italy).
ormorant Garamond is a classic font with a modern twist. It's easy to read on screens of every shape and size, and perfect for long blocks of text.
C
Dr. Nicola Redi brings nearly 30 years experience in translating science into products, companies and investments. He is currently managing Obloo Ventures, a unique investment platform focusing on aerospace & defence, computational sciences, robotics and energy. He managed funds backing 70+ deep tech companies in the last 15 years and served in the investment committees of the French lifescience fund Technologie et Santé I (Sofimac Partners) and Atmos II renewable energy fund.
Before entering the deep tech venture capital arena, he joined leading multinational industrial corporations with Global and EMEA leadership positions in R&D and new product development. He also managed a manufacturing and service unit of automated and robotic machineries.
Nicola is also actively involved in policy making at European level (High Level Groups) and post graduate academic activities (core faculty member of MIB School of Management and Director of the Executive MBA in Business Innovation).
His diversified and sound education include: PhD in Management - Aston University in Birmingham, MBA with greatest honours - SDA Bocconi and MSc in Aerospace Engineering - Politecnico di Milano. Furthermore Nicola holds a YMP from INSEAD and is a Certified Process Kaizen Engineer.
